About D2l Pharma Research Solutions Private Limited
Data last updated: 11 January 2026
D2l Pharma Research Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 06 July 2007, the company has been in operation for over 19 years.
Registered with ROC Hyderabad under CIN U24232TG2007PTC054728.
Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹28.78 Lakh. It is led by directors including Marella Ravikant and Shekhar Gupta.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: H.No: 16 – 11 – 16/75 Plot No.75 Sripuram Colony Malakpet, Hyderabad, Telangana, India – 500036.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.09 Cr, a growth of 19% compared to the previous year.
The company has a workforce of approximately 47 employees as per the latest available data.
The company is associated with 1 brand - D2l Pharma Research Solutions. As per MCA filings, the company has open charges of ₹2.6 Cr and satisfied charges of ₹2.6 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website d2lpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressH.No: 16 – 11 – 16/75 Plot No.75 Sripuram Colony Malakpet, Hyderabad, Telangana, India – 500036
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited has one previous CIN (Corporate Identification Number): U24232AP2007PTC054728. The current CIN is U24232TG2007PTC054728, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC054728 | Current |
| U24232AP2007PTC054728 | Previous |
Associated Brands with D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited operates one associated brand: D2L Pharma Research Solutions. These brands represent D2l Pharma Research Solutions Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides consulting services for Key Opinion Leader development in pharmaceuticals. | d2lpharma.com |
Competitors & Alternatives of D2l Pharma Research Solutions Private Limited
Brands and companies operating in the same space as D2l Pharma Research Solutions Private Limited include Vastrax, Pharma-KOL, TIPMed and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Vastrax
|
Offers clinical, regulatory, and commercial support for vascular technology development. | Andover, United States, United States | 2016 |
Pharma-KOL
|
Provides Key Opinion Leader services to pharmaceutical companies. | Cranleigh, United Kingdom, United Kingdom | 2008 |
TIPMed
|
Platform for life sciences meeting and event management services. | Newport Beach, United States, United States | 2009 |
Clear Point Health
|
Offers tools for patient engagement, customer experience, and thought leader profiling in healthcare. | Chapel Hill, United States, United States | 2003 |
Meta Research
|
Meta Research conducts qualitative market research for healthcare and pharmaceutical sectors. | Rome, Italy, Italy | 2000 |
Thought Leader Select
|
Delivers KOL-focused research, planning, insights, and engagement services. | Chapel Hill, United States, United States | 2006 |
Pharma Business
|
Provides consulting for R&D, business development, security, and international pharma needs. | - | 2011 |
Emerald Venture Partners
|
Delivers comprehensive business consulting services tailored to the biopharma sector. | Kansas, United States, United States | 2017 |
Business Activity of D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including management consultancy activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities | Locked |
Business activity turnover details for D2l Pharma Research Solutions Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited is audited by MURALI & VENKAT for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MURALI & VENKAT | Locked | Locked | Locked |
Complete auditor history for D2l Pharma Research Solutions Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited is currently managed by 4 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Marella Ravikant | Whole-Time Director | 05 Feb 2010 | 16 Years 6 Months | Current |
| Shekhar Gupta | Whole-Time Director | 18 Jan 2008 | 18 Years 6 Months | Current |
| Kode Sashi Kiran | Managing Director | 06 Jul 2007 | 19 Years 1 Months | Current |
| Sudheesh Kookkal | Additional Director | 27 Oct 2025 | 0 Years 9 Months | Current |
Financials of D2l Pharma Research Solutions Private Limited FY 2025 filings available
D2l Pharma Research Solutions Private Limited reported revenue of ₹8.09 Cr (up 19.00% YoY) for FY 2025.
Ten-year financial statements for D2l Pharma Research Solutions Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of D2l Pharma Research Solutions Private Limited
Shareholding and ownership data for D2l Pharma Research Solutions Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of D2l Pharma Research Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2020 | Others | ₹2.6 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited has a workforce of 47 employees as of Mar 30, 2024.
Employee and EPFO history for D2l Pharma Research Solutions Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of D2l Pharma Research Solutions Private Limited
GST registrations and filing compliance for D2l Pharma Research Solutions Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for D2l Pharma Research Solutions Private Limited
Credit ratings, litigation, and regulatory alerts for D2l Pharma Research Solutions Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by D2l Pharma Research Solutions Private Limited
MSME payment history for D2l Pharma Research Solutions Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of D2l Pharma Research Solutions Private Limited
Corporate group structure for D2l Pharma Research Solutions Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of D2l Pharma Research Solutions Private Limited
MCA filings and documents for D2l Pharma Research Solutions Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on D2l Pharma Research Solutions Private Limited
Frequently Asked Questions about D2l Pharma Research Solutions Private Limited
D2l Pharma Research Solutions Private Limited is an active private limited company in the life sciences sector based in Hyderabad, Telangana, India. It was incorporated on 06 July 2007 (19+ years old) and is registered under CIN U24232TG2007PTC054728. The company has 47 employees.
D2l Pharma Research Solutions Private Limited reported revenue of ₹8.09 Cr for FY 2025 (up 19.00% YoY).
The current directors of D2l Pharma Research Solutions Private Limited are:
- Marella Ravikant - Whole-Time Director
- Shekhar Gupta - Whole-Time Director
- Kode Sashi Kiran - Managing Director
- Sudheesh Kookkal - Additional Director
The primary industry of D2l Pharma Research Solutions Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
D2l Pharma Research Solutions Private Limited can be reached at the registered office: H.No: 16 – 11 – 1675 Plot No.75 Sripuram Colony Malakpet, Hyderabad, Telangana, India – 500036, or through the website d2lpharma.com.
The authorised capital is ₹50 Lakh, and the paid-up capital is ₹28.78 Lakh.